Clinical Trials Browser

Not yet recruiting × INDUSTRY × Hematologic Neoplasms × Clear all

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07294300 2025-12-19

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

Phase 1 Not yet recruiting

124 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06225050 2025-12-03

HAPLO2022

Phase NA Not yet recruiting

18 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07255898 2025-12-01

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Phase 1 Not yet recruiting

33 enrolled

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

Phase 1/2 Not yet recruiting

116 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT06333509 2024-03-27

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL